Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97343167 | 9734316 | 7 | F | 20121017 | 20160816 | 20131206 | 20160819 | EXP | BR-ROCHE-1146815 | ROCHE | 36.81 | YR | F | Y | 90.00000 | KG | 20160819 | CN | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 97343167 | 9734316 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DATE OF MOST RECENT DOSE : MAY/2013 | U | 103705 | 500 | MG | SOLUTION FOR INFUSION | ||||||
| 97343167 | 9734316 | 2 | SS | TRAMAL | TRAMADOL | 1 | Unknown | U | 0 | ||||||||||
| 97343167 | 9734316 | 3 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 0 | 25 | MG | TABLET | BID | |||||||
| 97343167 | 9734316 | 4 | C | NEUTROFER | FERROUS BISGLYCINATE | 1 | 0 | ||||||||||||
| 97343167 | 9734316 | 5 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 15 MG TABLET SPLITED IN TWO | 0 | 7.5 | MG | TABLET | BID | ||||||
| 97343167 | 9734316 | 6 | C | SULFASALAZINE. | SULFASALAZINE | 1 | Unknown | 2 TABLETS AFTER LUNCH AND 2 AFTER DINNER | 0 | 500 | MG | TABLET | QID | ||||||
| 97343167 | 9734316 | 7 | C | FLUOXETINE | FLUOXETINE HYDROCHLORIDE | 1 | Unknown | 0 | 20 | MG | |||||||||
| 97343167 | 9734316 | 8 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | Unknown | 0 | 200 | MG | |||||||||
| 97343167 | 9734316 | 9 | C | LOSARTAN. | LOSARTAN | 1 | Unknown | 0 | 50 | MG | TABLET | QD | |||||||
| 97343167 | 9734316 | 10 | C | NEUTROFER | FERROUS BISGLYCINATE | 1 | Unknown | 0 | 150 | MG | |||||||||
| 97343167 | 9734316 | 11 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 97343167 | 9734316 | 1 | Rheumatoid arthritis |
| 97343167 | 9734316 | 2 | Product used for unknown indication |
| 97343167 | 9734316 | 3 | Hypertension |
| 97343167 | 9734316 | 6 | Rheumatoid arthritis |
| 97343167 | 9734316 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 97343167 | 9734316 | HO |
| 97343167 | 9734316 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 97343167 | 9734316 | Dizziness | |
| 97343167 | 9734316 | Fibromyalgia | |
| 97343167 | 9734316 | Gastritis | |
| 97343167 | 9734316 | Genital haemorrhage | |
| 97343167 | 9734316 | Haemorrhage | |
| 97343167 | 9734316 | Hypersensitivity | |
| 97343167 | 9734316 | Kidney infection | |
| 97343167 | 9734316 | Nephrolithiasis | |
| 97343167 | 9734316 | Osteoarthritis | |
| 97343167 | 9734316 | Pain | |
| 97343167 | 9734316 | Urinary tract infection | |
| 97343167 | 9734316 | Uterine disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 97343167 | 9734316 | 1 | 20121017 | 0 |